Impact of intra-tumoral heterogeneity detected by next-generation sequencing on acute myeloid leukemia survival

Click to increase image sizeClick to decrease image size

Acknowledgements

This research was funded in part by the ACLPS Paul E. Strandjord Young Investigator Grant. The authors would like to thank the Yale University School of Medicine Laboratory Medicine Molecular Diagnostics lab for the clinical sequencing effort as well as the Yale University School of Medicine Department of Hematology.

Author contributions

W.S. designed the study, analyzed the data, and wrote the manuscript, H.R. wrote the manuscript, T.D. performed the analysis, C.T. collected data, R.T. collected data, B.S. wrote the manuscript, K.H. analyzed and collected the data, J.H. collected the data, A.S. designed the study and wrote the manuscript. The authors have no relevant financial or commercial relationships to disclose.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The present research was financially supported by Academy of Clinical Laboratory Physicians and Scientists.